Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine G Beuerlein

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Dermatology Online Journal|February 12, 2020
Multidermatomal herpes zoster: a pain in the neck?Katherine G Beuerlein, Lindsay C Strowd
Cutis|June 6, 2022
Interstitial Granulomatous Dermatitis as an Adverse Reaction to VedolizumabKatherine G Beuerlein, Elise D Martin, Lindsay C Strowd
Dermatology Online Journal|November 10, 2021
Morgellons disease etiology and therapeutic approach: a systematic reviewKatherine G Beuerlein, Esther A Balogh, Steven R Feldman
Expert Opinion on Pharmacotherapy|January 25, 2022
Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspectiveEsther A Balogh, Katherine G Beuerlein, Steven R Feldman
The American Journal of Dermatopathology|April 15, 2022
Ulcerative Lesions and Diarrhea: ChallengeKatherine G Beuerlein, Nathan L Bowers, Jessica Savas, et al.
The American Journal of Dermatopathology|April 15, 2022
Ulcerative Lesions and Diarrhea: AnswerKatherine G Beuerlein, Nathan L Bowers, Jessica Savas, et al.
The Journal of Dermatological Treatment|September 8, 2021
Should atopic dermatitis patients starting JAK inhibitors take prophylactic acyclovir?Milaan A Shah, Katherine G Beuerlein, Joseph L Jorizzo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Dermatology Online Journal|February 12, 2020
Multidermatomal herpes zoster: a pain in the neck?Katherine G Beuerlein, Lindsay C Strowd
Cutis|June 6, 2022
Interstitial Granulomatous Dermatitis as an Adverse Reaction to VedolizumabKatherine G Beuerlein, Elise D Martin, Lindsay C Strowd
Dermatology Online Journal|November 10, 2021
Morgellons disease etiology and therapeutic approach: a systematic reviewKatherine G Beuerlein, Esther A Balogh, Steven R Feldman
Expert Opinion on Pharmacotherapy|January 25, 2022
Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspectiveEsther A Balogh, Katherine G Beuerlein, Steven R Feldman
The American Journal of Dermatopathology|April 15, 2022
Ulcerative Lesions and Diarrhea: ChallengeKatherine G Beuerlein, Nathan L Bowers, Jessica Savas, et al.
The American Journal of Dermatopathology|April 15, 2022
Ulcerative Lesions and Diarrhea: AnswerKatherine G Beuerlein, Nathan L Bowers, Jessica Savas, et al.
The Journal of Dermatological Treatment|September 8, 2021
Should atopic dermatitis patients starting JAK inhibitors take prophylactic acyclovir?Milaan A Shah, Katherine G Beuerlein, Joseph L Jorizzo, et al.
Pageof 1